Difficulty: Medium
Average Score: 79%
Practice
Oral and intravenous atropine sulfate (pyloric muscle relaxant) has been described when surgical treatment is not available for hypertrophic pyloric stenosis with a success rate of
Correct answer
C
Rationale
Atropine sulfate, a pyloric muscle relaxant, is used as a temporary measure in hypertrophic pyloric stenosis when surgical intervention is not immediately available. The success rate of oral and intravenous atropine sulfate in treating this condition is around 60%. This success is attributed to the ability of atropine to inhibit acetylcholine receptors, which helps in relaxing the hypertrophied pyloric muscle and improving gastric outlet obstruction.
Option A (20%) is incorrect because a success rate of 20% would indicate a much lower effectiveness of atropine sulfate in treating hypertrophic pyloric stenosis. This rate would not support the widespread use of atropine in this condition.
Option B (40%) is also incorrect as a success rate of 40% would suggest a moderate effectiveness of atropine, which is lower than the actual success rate observed in clinical practice.
Option D (80%) is incorrect because while atropine is effective in many cases, an 80% success rate would overestimate its efficacy in treating hypertrophic pyloric stenosis without surgical intervention.
Educationally, understanding the success rate of atropine sulfate in hypertrophic pyloric stenosis is crucial for healthcare professionals working with pediatric patients. It highlights the importance of early diagnosis and timely surgical intervention in cases where atropine treatment may not be sufficient. This knowledge can help in making informed clinical decisions and providing optimal care for children with GI disorders.
Option A (20%) is incorrect because a success rate of 20% would indicate a much lower effectiveness of atropine sulfate in treating hypertrophic pyloric stenosis. This rate would not support the widespread use of atropine in this condition.
Option B (40%) is also incorrect as a success rate of 40% would suggest a moderate effectiveness of atropine, which is lower than the actual success rate observed in clinical practice.
Option D (80%) is incorrect because while atropine is effective in many cases, an 80% success rate would overestimate its efficacy in treating hypertrophic pyloric stenosis without surgical intervention.
Educationally, understanding the success rate of atropine sulfate in hypertrophic pyloric stenosis is crucial for healthcare professionals working with pediatric patients. It highlights the importance of early diagnosis and timely surgical intervention in cases where atropine treatment may not be sufficient. This knowledge can help in making informed clinical decisions and providing optimal care for children with GI disorders.